ELAVL1 and urinary bladder cancer: It was found in humans and animal models that METTL3 (Cheng et al., 2019; Jin et al., 2019; Xie et al., 2020), FTO (Tao et al., 2021; Zhou et al., 2021), IGF2BP1 (Xie et al., 2021), IGF2BP3, YTHDF1 (Zhu et al., 2023), YTHDF 2, ELAV-like protein 1 (ELAVL1), HNRNPA2B1 (Deng et al., 2022) were upregulated in bladder cancer cells.